Brief: Celldex Therapeutics Announces Pricing Of Upsized $400 Mln Public Offering Of Common Stock
Feb 29 (Reuters) - Celldex Therapeutics Inc CLDX.O :
* CELLDEX THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $400
MILLION
PUBLIC OFFERING OF COMMON STOCK
* CELLDEX THERAPEUTICS INC - UPSIZED UNDERWRITTEN PUBLIC
OFFERING
OF 8.5 MILLION SHARES OF ITS COMMON STOCK AT A PUBLIC OFFERING
PRICE OF $47.00 PER SHARE
Source text for Eikon: ID:nGNX5dDb2J
Further company coverage: CLDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials